These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925 [TBL] [Abstract][Full Text] [Related]
3. The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate. Drijgers RL; Verhey FR; Tissingh G; van Domburg PH; Aalten P; Leentjens AF J Neurol Sci; 2012 Sep; 320(1-2):121-6. PubMed ID: 22824349 [TBL] [Abstract][Full Text] [Related]
5. The system-neurophysiological basis for how methylphenidate modulates perceptual-attentional conflicts during auditory processing. Adelhöfer N; Gohil K; Passow S; Teufert B; Roessner V; Li SC; Beste C Hum Brain Mapp; 2018 Dec; 39(12):5050-5061. PubMed ID: 30133058 [TBL] [Abstract][Full Text] [Related]
6. Influence of methylphenidate on eating in obese men. Leddy JJ; Epstein LH; Jaroni JL; Roemmich JN; Paluch RA; Goldfield GS; Lerman C Obes Res; 2004 Feb; 12(2):224-32. PubMed ID: 14981214 [TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082 [TBL] [Abstract][Full Text] [Related]
8. Dopamine Modulates the Efficiency of Sensory Evidence Accumulation During Perceptual Decision Making. Beste C; Adelhöfer N; Gohil K; Passow S; Roessner V; Li SC Int J Neuropsychopharmacol; 2018 Jul; 21(7):649-655. PubMed ID: 29618012 [TBL] [Abstract][Full Text] [Related]
9. Interplay of neuronal processes during response inhibition: results from a combined event-related potentials (ERPs)/transcranial magnetic stimulation (TMS) study on methylphenidate. Hoegl T; Heinrich H; Albrecht B; Diruf M; Moll GH; Kratz O Int J Psychophysiol; 2011 Aug; 81(2):99-106. PubMed ID: 21620906 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates. Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600 [TBL] [Abstract][Full Text] [Related]
11. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylphenidate challenge. Schlösser RG; Nenadic I; Wagner G; Zysset S; Koch K; Sauer H Synapse; 2009 May; 63(5):429-42. PubMed ID: 19184997 [TBL] [Abstract][Full Text] [Related]
13. Cortical and subcortical distribution of middle and long latency auditory and visual evoked potentials in a cognitive (CNV) paradigm. Bares M; Rektor I; Kanovský P; Streitová H Clin Neurophysiol; 2003 Dec; 114(12):2447-60. PubMed ID: 14652105 [TBL] [Abstract][Full Text] [Related]
14. The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study. Korostenskaja M; Kicić D; Kähkönen S Psychopharmacology (Berl); 2008 Apr; 197(3):475-86. PubMed ID: 18264697 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254 [TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of methylphenidate and levodopa in healthy volunteers. Linssen AM; Sambeth A; Vuurman EF; Riedel WJ Eur Neuropsychopharmacol; 2014 Feb; 24(2):200-6. PubMed ID: 24119823 [TBL] [Abstract][Full Text] [Related]
18. Further studies of effects of chlorpromazine on the contingent negative variation. Kuda K; Fujitani Y; Oikawa T Folia Psychiatr Neurol Jpn; 1978; 32(4):579-84. PubMed ID: 750345 [TBL] [Abstract][Full Text] [Related]
19. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations. Calipari ES; Ferris MJ; Melchior JR; Bermejo K; Salahpour A; Roberts DC; Jones SR Addict Biol; 2014 Mar; 19(2):145-55. PubMed ID: 22458761 [TBL] [Abstract][Full Text] [Related]
20. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]